Ramesh Kannan
Finance
Somerset Indus Capital taps local LP for third private equity fund
Healthcare-focused private equity firm Somerset Indus Capital Partners has secured a capital commitment from a domestic institutional investor for its ......
Healthcare
Healthcare PE firm Somerset exits diagnostics chain with stellar returns
Somerset Indus Capital Partners, a private equity firm focused on healthcare that is on the road to raise its third ......
Finance
Somerset's Ramesh Kannan on planned exits, new fund and why many investors shun hospitals
Somerset Indus Capital Partners, a healthcare-focused private equity firm that has invested in companies such as Krsnaa Diagnostics, Sandor Medicaids, ......
Healthcare
Somerset Indus Capital set to launch third fund
Healthcare-focused private equity firm Somerset Indus Capital Partners is planning to launch its third India fund at $200-220 million in ......
Healthcare
Healthcare 2021: Healthtech shines; diagnostics, hospitals keep up with IPOs, M&As
India’s healthtech segment made great strides in 2021, with the landmark acquisition of a listed company - Thyrocare Technologies, by ......
Healthcare
PE firms shift focus from traditional healthcare to healthtech investments post Covid
Private equity (PE) firms that were in favour of investing only in traditional healthcare companies are now warming up to ......
Healthcare
Debut fund has four exits in the works: Somerset partner Ramesh Kannan
Earlier this month, the debut fund of healthcare-focused private equity firm Somerset Indus Capital Partners made its first partial exit ......
Healthcare
Flashback 2020: Vaccine makers, healthtech in spotlight as Covid-19 rages
Indian vaccine makers took centre stage in 2020 as the country and emerging markets pinned their hopes on them to ......
Healthcare
Sector watch: Will COVID-19 strengthen big diagnostics firms, spur consolidation?
When Nalanda Capital bet on Thyrocare Technologies Ltd in March, the private equity-style investor in public equities was likely enticed ......
Finance
Somerset's Ramesh Kannan on exit plans and pandemic's impact on portfolio firms
Healthcare-focused private equity firm Somerset Indus Capital Partners is concentrating on exiting its debut fund’s portfolio companies and striking new ......